Angela Chiavegato

Angela Chiavegato

Auto-generated profile, based on publicly available information

Angela Chiavegato

Institute of Neuroscience, National Research Council, Padova section

Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 October 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
GLGabriele Losi
Gabriele Losi
BVBeatrice Vignoli
Beatrice Vignoli
RGRocco Granata
Rocco Granata
ALAnnamaria Lia
Annamaria Lia
MICAELA ZONTAMICAELA ZONTA
MICAELA ZONTA
MCMarco Canossa
Marco Canossa
In the absence of explicit neuronal inputs, the glial cell astrocytes exhibit recurring intracellular Ca 2+ fluctuations, primarily localized at thin processes, known as Ca 2+ microdomains (MDs). Although spontaneous Ca 2+ MDs are present throughout the brain, their putative role is unknown. Here, we question whether, owing to their recurring signaling mode, spontaneous Ca 2+ MDs contribute to slowly evolving phenomena in the brain, such as memory consolidation. We demonstrate that, in the perirhinal cortex, a central region in recognition memory, these events promote Ca 2+ -dependent gliotransmission and modulate synaptic strengthening. Their recurring activity extends the release of the gliotransmitter brain-derived neurotrophic factor (BDNF) over time, ensuring the sustained Tropomyosin Receptor Kinase B (TrkB)-signaling required for the consolidation of long-term synaptic potentiation and lasting memories. We also show that Ca 2+ MDs, which are stochastic events, preserve their random behavior during gliotransmission, introducing an element of unpredictability into the process of memory retention. Our study assigns to spontaneous, stochastic activity in astrocytes a unique functional role in shaping and stabilizing memory circuits.

19 December 1995 in Cell and tissue research
Verified
Journal Article
Closed access
PDF file
ACAngela Chiavegato
Angela Chiavegato
ACAlessandra Capriani
Alessandra Capriani
GAGiuseppe Azzarello
Giuseppe Azzarello
OVOrazio Vinante
Orazio Vinante
PPPaolo Pauletto
Paolo Pauletto
SSSaverio Sartore
Saverio Sartore

23 August 2025 in Neurochemical Research
Verified
Journal Article
Open access
PDF file
ASAlessandro Di Spiezio
Alessandro Di Spiezio
MGMARTA GOMEZ GONZALO
MARTA GOMEZ GONZALO
ACAngela Chiavegato
Angela Chiavegato
MICAELA ZONTAMICAELA ZONTA
MICAELA ZONTA
Chronic pain is a debilitating, life-altering condition that affects a significant portion of the global population, impacting approximately one fifth of people in Europe and one third of people worldwide. Clinical and experimental efforts are increasingly converging to deepen our comprehension of the molecular, cellular and circuit-level mechanisms underlying persistent pain. While most studies have traditionally focused on alterations of nociceptive pathways in neurons, growing evidence highlights the critical role of astrocytes in modulating these pathways and contributing to the development of the central sensitization that characterizes chronic pain. Moreover, astrocytes are also implicated in pain-associated maladaptive behaviours and cognitive impairments. In this context, we review the latest findings on astrocyte involvement in chronic pain and its related mood and cognitive comorbidities. Graphical Abstract

23 November 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
LILudovica Iovino
Ludovica Iovino
JVJared VanderZwaag
Jared VanderZwaag
GKGurkirat Kaur
Gurkirat Kaur
PKParsa Khakpour
Parsa Khakpour
VGVeronica Giusti
Veronica Giusti
LCLaura Civiero
Laura Civiero
Microglia, the central nervous system resident immune cells, are now recognized to critically impact homeostasis maintenance and contribute to the outcomes of various pathological conditions including Parkinson’s disease (PD). Microglia are heterogenous, with a variety of states recently identified in aging and neurodegenerative disease models, including the ‘disease-associated microglia’ (DAM) which present a selective enrichment of CLEC7A encoding the CLEC7A or DECTIN1 protein, and the ‘dark microglia’ (DM) displaying markers of cellular stress at the ultrastructural level. However, the roles of CLEC7A-positive microglia and DM in the pathology of PD have remained largely elusive. By applying immunofluorescence and scanning electron microscopy, we aimed to characterize 1) the CLEC7A -positive cell population, and 2) their possible relationships to DM in a mouse model harboring a G2019S pathogenic mutation of the LRRK2 gene, the most common mutation linked to PD. We examined 18-month-old mice, comparing between LRRK2 G2019S knock-in mice and wild-type controls. In the dorsal striatum, a region affected by PD pathology, extensive ultrastructural features of cellular stress (e.g., endoplasmic reticulum and Golgi apparatus dilation), as well as reduced direct cellular contacts, were observed for microglia from LRRK2 G2019S mice versus controls. CLEC7A-positive microglia exhibited extensive phagocytic ultrastructural characteristics in the LRRK2 G2019S mice. Additionally, the LRRK2 G2019S mice presented a higher proportion of DM. Lastly, immunofluorescence and biochemical analysis revealed higher number of CLEC7A-positive cells in Lrrk2 G2019S genotype versus controls both in tissues and in primary microglia cells. Of note, CLEC7A-positive cells present a selective enrichment of ameboid morphology and tend to cluster in the pathogenic animal. In summary, we provide novel insights into the involvement of recently-defined microglial states, CLEC7A-positive cells and DM, in the context of LRRK2 G2019S PD pathology.